| 000 | 01919 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514233338.0 | ||
| 264 | 0 | _c20060126 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a0923-7534 | ||
| 024 | 7 |
_a10.1093/annonc/mdi316 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWestra, J L | |
| 245 | 0 | 0 |
_aPredictive value of thymidylate synthase and dihydropyrimidine dehydrogenase protein expression on survival in adjuvantly treated stage III colon cancer patients. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cOct 2005 |
||
| 300 |
_a1646-53 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAge of Onset |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xbiosynthesis |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aColonic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDNA Mutational Analysis |
| 650 | 0 | 4 |
_aDihydrouracil Dehydrogenase (NADP) _xbiosynthesis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aGenes, p53 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aThymidylate Synthase _xbiosynthesis |
| 700 | 1 | _aHollema, H | |
| 700 | 1 | _aSchaapveld, M | |
| 700 | 1 | _aPlatteel, I | |
| 700 | 1 | _aOien, K A | |
| 700 | 1 | _aKeith, W N | |
| 700 | 1 | _aMauritz, R | |
| 700 | 1 | _aPeters, G J | |
| 700 | 1 | _aBuys, C H C M | |
| 700 | 1 | _aHofstra, R M W | |
| 700 | 1 | _aPlukker, J Th M | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 16 _gno. 10 _gp. 1646-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdi316 _zAvailable from publisher's website |
| 999 |
_c15668043 _d15668043 |
||